Rhenman & Partners Asset Management AB as of Dec. 31, 2016
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 108 positions in its portfolio as reported in the December 2016 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Gilead Sciences (GILD) | 3.6 | $19M | 260k | 71.61 | |
Bristol Myers Squibb (BMY) | 3.1 | $16M | 281k | 58.44 | |
Allergan | 3.1 | $16M | 76k | 210.01 | |
Eli Lilly & Co. (LLY) | 3.0 | $16M | 215k | 73.55 | |
Medtronic (MDT) | 2.9 | $15M | 215k | 71.23 | |
Incyte Corporation (INCY) | 2.7 | $14M | 140k | 100.27 | |
Teva Pharmaceutical Industries (TEVA) | 2.5 | $13M | 360k | 36.25 | |
Exelixis (EXEL) | 2.4 | $12M | 830k | 14.91 | |
UnitedHealth (UNH) | 2.3 | $12M | 75k | 160.04 | |
Abiomed | 2.2 | $12M | 103k | 112.68 | |
Horizon Pharma | 2.2 | $11M | 700k | 16.18 | |
Alexion Pharmaceuticals | 2.1 | $11M | 92k | 122.35 | |
Ariad Pharmaceuticals | 2.1 | $11M | 895k | 12.44 | |
CVS Caremark Corporation (CVS) | 2.1 | $11M | 140k | 78.91 | |
Pfizer (PFE) | 2.1 | $11M | 333k | 32.48 | |
Celgene Corporation | 2.1 | $11M | 93k | 115.75 | |
Biogen Idec (BIIB) | 2.0 | $10M | 36k | 283.58 | |
Regeneron Pharmaceuticals (REGN) | 1.9 | $9.7M | 27k | 367.09 | |
Amgen (AMGN) | 1.8 | $9.5M | 65k | 146.22 | |
CIGNA Corporation | 1.8 | $9.2M | 69k | 133.39 | |
Centene Corporation (CNC) | 1.6 | $8.5M | 150k | 56.51 | |
Anthem (ELV) | 1.6 | $8.4M | 58k | 143.78 | |
Zimmer Holdings (ZBH) | 1.6 | $8.3M | 80k | 103.20 | |
Humana (HUM) | 1.6 | $8.2M | 40k | 204.02 | |
Hca Holdings (HCA) | 1.5 | $7.8M | 105k | 74.02 | |
Aetna | 1.5 | $7.7M | 62k | 124.02 | |
Express Scripts Holding | 1.5 | $7.6M | 111k | 68.79 | |
Abbvie (ABBV) | 1.4 | $7.2M | 115k | 62.62 | |
Edwards Lifesciences (EW) | 1.3 | $6.6M | 70k | 93.70 | |
Nevro (NVRO) | 1.2 | $6.5M | 89k | 72.66 | |
Hologic (HOLX) | 1.2 | $6.4M | 160k | 40.12 | |
Thermo Fisher Scientific (TMO) | 1.2 | $6.3M | 45k | 141.11 | |
Supernus Pharmaceuticals (SUPN) | 1.2 | $6.3M | 250k | 25.25 | |
Xencor (XNCR) | 1.1 | $5.9M | 225k | 26.32 | |
Jazz Pharmaceuticals (JAZZ) | 1.1 | $5.6M | 51k | 109.03 | |
Zeltiq Aesthetics | 1.0 | $5.4M | 125k | 43.52 | |
AmerisourceBergen (COR) | 1.0 | $5.3M | 68k | 78.19 | |
Dex (DXCM) | 1.0 | $5.1M | 85k | 59.71 | |
Alnylam Pharmaceuticals (ALNY) | 1.0 | $5.1M | 135k | 37.44 | |
Nektar Therapeutics (NKTR) | 1.0 | $5.0M | 410k | 12.27 | |
Endo International | 0.9 | $4.9M | 300k | 16.47 | |
Array BioPharma | 0.9 | $4.8M | 550k | 8.79 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.9 | $4.8M | 65k | 73.68 | |
Cardinal Health (CAH) | 0.9 | $4.7M | 65k | 71.97 | |
Lion Biotechnologies | 0.9 | $4.5M | 650k | 6.95 | |
Intra Cellular Therapies (ITCI) | 0.8 | $4.4M | 290k | 15.09 | |
Revance Therapeutics (RVNC) | 0.8 | $4.3M | 210k | 20.70 | |
Alkermes (ALKS) | 0.8 | $4.2M | 76k | 55.58 | |
NxStage Medical | 0.8 | $4.2M | 159k | 26.21 | |
BioMarin Pharmaceutical (BMRN) | 0.8 | $4.1M | 50k | 82.84 | |
Merck & Co (MRK) | 0.8 | $4.1M | 70k | 58.87 | |
Omnicell (OMCL) | 0.8 | $4.0M | 119k | 33.90 | |
Glaukos (GKOS) | 0.8 | $4.0M | 116k | 34.30 | |
Laboratory Corp. of America Holdings | 0.7 | $3.9M | 30k | 128.37 | |
Kite Pharma | 0.7 | $3.6M | 80k | 44.84 | |
Livanova Plc Ord (LIVN) | 0.7 | $3.6M | 80k | 44.98 | |
Esperion Therapeutics (ESPR) | 0.7 | $3.4M | 275k | 12.52 | |
Endologix | 0.6 | $3.3M | 575k | 5.72 | |
Universal Health Services (UHS) | 0.6 | $3.2M | 30k | 106.37 | |
Macrogenics (MGNX) | 0.6 | $3.2M | 155k | 20.44 | |
Neuroderm Ltd F | 0.6 | $3.2M | 143k | 22.20 | |
Coherus Biosciences (CHRS) | 0.6 | $3.1M | 111k | 28.15 | |
Rigel Pharmaceuticals | 0.6 | $3.1M | 1.3M | 2.38 | |
DaVita (DVA) | 0.6 | $2.9M | 45k | 64.20 | |
Tesaro | 0.5 | $2.7M | 20k | 134.50 | |
Portola Pharmaceuticals | 0.5 | $2.7M | 121k | 22.44 | |
Keryx Biopharmaceuticals | 0.5 | $2.5M | 425k | 5.86 | |
Fibrogen (FGEN) | 0.4 | $2.2M | 104k | 21.40 | |
Intercept Pharmaceuticals In | 0.4 | $2.2M | 20k | 108.65 | |
Adamas Pharmaceuticals | 0.4 | $2.2M | 130k | 16.90 | |
Perrigo Company (PRGO) | 0.4 | $2.1M | 25k | 83.24 | |
Radius Health | 0.4 | $2.1M | 55k | 38.04 | |
Walgreen Boots Alliance (WBA) | 0.4 | $2.1M | 25k | 82.76 | |
ACADIA Pharmaceuticals (ACAD) | 0.4 | $2.0M | 70k | 28.84 | |
Illumina (ILMN) | 0.4 | $1.9M | 15k | 128.07 | |
Dynavax Technologies (DVAX) | 0.4 | $1.9M | 485k | 3.95 | |
Chimerix (CMRX) | 0.3 | $1.8M | 400k | 4.60 | |
Halozyme Therapeutics (HALO) | 0.3 | $1.8M | 180k | 9.88 | |
Neurocrine Biosciences (NBIX) | 0.3 | $1.5M | 40k | 38.70 | |
Insulet Corporation (PODD) | 0.2 | $1.3M | 35k | 37.69 | |
Aerie Pharmaceuticals | 0.2 | $1.3M | 35k | 37.86 | |
Tetraphase Pharmaceuticals | 0.2 | $1.2M | 300k | 4.03 | |
Regulus Therapeutics | 0.2 | $1.1M | 468k | 2.25 | |
Becton, Dickinson and (BDX) | 0.2 | $828k | 5.0k | 165.60 | |
Achillion Pharmaceuticals | 0.1 | $686k | 166k | 4.13 | |
Mednax (MD) | 0.1 | $600k | 9.0k | 66.67 | |
Tandem Diabetes Care | 0.1 | $503k | 234k | 2.15 | |
Adverum Biotechnologies | 0.1 | $447k | 154k | 2.90 | |
JPMorgan Chase & Co. (JPM) | 0.1 | $353k | 4.1k | 86.37 | |
Mylan Nv | 0.1 | $382k | 10k | 38.20 | |
Catabasis Pharmaceuticals | 0.1 | $361k | 100k | 3.61 | |
Microsoft Corporation (MSFT) | 0.1 | $298k | 4.8k | 62.17 | |
Exxon Mobil Corporation (XOM) | 0.1 | $288k | 3.2k | 90.14 | |
Wells Fargo & Company (WFC) | 0.1 | $337k | 6.1k | 55.08 | |
STAAR Surgical Company (STAA) | 0.1 | $312k | 29k | 10.87 | |
International Business Machines (IBM) | 0.1 | $293k | 1.8k | 165.91 | |
Concert Pharmaceuticals I equity | 0.1 | $310k | 30k | 10.30 | |
Ocular Therapeutix (OCUL) | 0.1 | $335k | 40k | 8.38 | |
Halliburton Company (HAL) | 0.1 | $267k | 4.9k | 54.15 | |
Qualcomm (QCOM) | 0.1 | $269k | 4.1k | 65.20 | |
Ford Motor Company (F) | 0.1 | $273k | 23k | 12.13 | |
Mirati Therapeutics | 0.1 | $238k | 50k | 4.76 | |
Anheuser-Busch InBev NV (BUD) | 0.0 | $230k | 2.2k | 105.50 | |
Orexigen Therapeutics | 0.0 | $209k | 120k | 1.74 | |
Caterpillar (CAT) | 0.0 | $144k | 1.5k | 93.02 | |
Threshold Pharmaceuticals | 0.0 | $89k | 202k | 0.44 | |
Anthera Pharmaceutcls | 0.0 | $130k | 200k | 0.65 | |
Ophthotech | 0.0 | $116k | 24k | 4.85 |